Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.329 EUR | -0.90% | -8.10% | -8.61% |
Apr. 17 | Intrasense: an innovative solution for cancer monitoring | CF |
Apr. 09 | Guerbet: CE certificate for a platform | CF |
Sales 2022 | 3.79M 4.08M | Sales 2023 | 3.3M 3.56M | Capitalization | 18.8M 20.24M |
---|---|---|---|---|---|
Net income 2022 | -3M -3.23M | Net income 2023 | -3M -3.23M | EV / Sales 2022 | 2.85 x |
Net Debt 2022 | 650K 700K | Net cash position 2023 | 3.06M 3.3M | EV / Sales 2023 | 4.76 x |
P/E ratio 2022 |
-2.97
x | P/E ratio 2023 |
-5.16
x | Employees | 74 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.57% |
1 day | -0.90% | ||
1 week | -8.10% | ||
Current month | -8.36% | ||
1 month | -0.60% | ||
3 months | +6.13% | ||
6 months | -13.42% | ||
Current year | -8.61% |
Managers | Title | Age | Since |
---|---|---|---|
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Julien Coste
DFI | Director of Finance/CFO | - | - |
Frédéric Champ
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michèle Lesieur
CHM | Chairman | 65 | 20-10-07 |
Patrice Rullier
BRD | Director/Board Member | 63 | 19-03-14 |
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.329 | -0.90% | 20,380 |
24-05-09 | 0.332 | 0.00% | 9,603 |
24-05-08 | 0.332 | -4.87% | 11,739 |
24-05-07 | 0.349 | -2.51% | 49,395 |
24-05-06 | 0.358 | 0.00% | 3,251 |
Real-time Euronext Paris, May 10, 2024 at 11:22 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.61% | 18.5M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- ALINS Stock